Curcumin — research review 3

...and this anti-inflammatory action is crucial because chronic, low-grade inflammation, often called “inflammaging,” is a major driver of age-related decline. Curcumin, a polyphenol, helps dampen that inflammatory signaling.

Right, and it does this through its redox and antioxidant pathways. We see some compelling evidence, for example, a review in Antioxidants in 2022, highlighting curcumin's role in modulating these inflammatory responses. It's not just a general anti-inflammatory; it seems quite targeted in some ways.

Exactly. But what's still genuinely unknown here? We have in vitro and animal studies showing significant benefits, but translating those to consistent, proven human outcomes for longevity markers is where the questions really begin. Are the dosages in supplements bioavailable enough to reach therapeutic levels in humans?

That’s a huge point. Bioavailability is a big hurdle for curcumin. Many formulations try to address this, but we don't have definitive, large-scale human trials demonstrating its direct impact on human lifespan or major age-related disease incidence in a way that’s widely accepted. We know it dampens inflammatory signaling, but does that prevent or significantly reverse inflammaging's broader effects in humans long-term? That's still unproven.

Precisely. We see the mechanisms, we see the potential, but the long-term human proof, the gold standard, is still an open question for many of these longevity compounds.